Market Cap 948.89M
Revenue (ttm) 28.83M
Net Income (ttm) -162.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -564.90%
Debt to Equity Ratio 0.00
Volume 1,657,000
Avg Vol 4,135,436
Day's Range N/A - N/A
Shares Out 299.34M
Stochastic %K 72%
Beta 0.81
Analysts Strong Sell
Price Target $9.00

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research coll...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 West 4th Ave, Vancouver, Canada
Rastafari
Rastafari Feb. 19 at 2:41 AM
$ABCL According to the most recent publicly-available institutional filings, SoftBank Group Corp. purchased approximately 345,000 shares of AbCellera Biologics Inc. (ticker: ABCL) in the quarter reported for Q4 2025. This position is very small relative to its overall portfolio — about 345,160 shares according to SoftBank’s 13F disclosure — and represents the extent of SoftBank’s reported ABCL holding in that filing period
0 · Reply
tradersunion353
tradersunion353 Feb. 19 at 1:14 AM
$ABCL For the love of the longs… can we see $8 by April?
0 · Reply
raccoonblackbear
raccoonblackbear Feb. 18 at 2:32 PM
$ABCL Nvidia just sold everything they had of RXRX. Huge hit to the flagship AI biotech company. Think this will send money into companies like ABCL now or will ABCL get dragged down in the process?
1 · Reply
VoidGorilla
VoidGorilla Feb. 17 at 3:23 PM
•• $ABCL $FBIO $SNDX $TGTX ••
0 · Reply
tradersunion353
tradersunion353 Feb. 17 at 3:18 PM
$ABCL Overhyped under performed stock From investors stand point buying and holding is okay but for not for several years with no real gains
1 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 17 at 2:27 PM
$ABCL Short to float ratio now at 21.29% — that’s 48.9 Million shares that must be bought back eventually as margin costs erode potential profits.
0 · Reply
Aye_Rooster
Aye_Rooster Feb. 17 at 1:06 PM
$ABCL Robinhood showing some action in Premarket - up 7.42%
1 · Reply
DragonAlgo
DragonAlgo Feb. 17 at 2:25 AM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2027-01-15 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $1.02 Stop: $0.74 TP1: $1.33 TP2: $1.74 TP3: $2.46 System-defined risk profile. 🔗 https://dragonalgo.com
0 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 16 at 2:07 PM
$ABCL Background for the next ER: The incredibly complex world of developing Monoclonal Antibodies. https://www.tandfonline.com/doi/full/10.1080/19420862.2024.2394229#d1e451 There is a list of abbreviations at the end. This article proves why $ABCL wants to build the best lab in the world and attract the best talent available to defeat the worst diseases on the planet. They did it with Covid. One reason among many that I am a heavy investor in Abcellera Biologics.
2 · Reply
DragonAlgo
DragonAlgo Feb. 16 at 9:31 AM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2027-01-15 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $1.02 Stop: $0.74 TP1: $1.33 TP2: $1.74 TP3: $2.46 System-defined risk profile. 🔗 https://dragonalgo.com
0 · Reply
Latest News on ABCL
AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 3 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 3 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics: Entering Growth Phase After A Pause

Oct 6, 2025, 7:35 AM EDT - 4 months ago

AbCellera Biologics: Entering Growth Phase After A Pause


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 5 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:33 PM EDT - 10 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 10 months ago

AbCellera Reports Q1 2025 Business Results


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics: Still A Concept Stock

Dec 23, 2024, 4:39 PM EST - 1 year ago

AbCellera Biologics: Still A Concept Stock


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera: A Platform To Pipeline Transition

Oct 14, 2024, 12:04 PM EDT - 1 year ago

AbCellera: A Platform To Pipeline Transition


AbCellera: A Waiting Game With High Uncertainty

Aug 23, 2024, 4:43 AM EDT - 1 year ago

AbCellera: A Waiting Game With High Uncertainty


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


Rastafari
Rastafari Feb. 19 at 2:41 AM
$ABCL According to the most recent publicly-available institutional filings, SoftBank Group Corp. purchased approximately 345,000 shares of AbCellera Biologics Inc. (ticker: ABCL) in the quarter reported for Q4 2025. This position is very small relative to its overall portfolio — about 345,160 shares according to SoftBank’s 13F disclosure — and represents the extent of SoftBank’s reported ABCL holding in that filing period
0 · Reply
tradersunion353
tradersunion353 Feb. 19 at 1:14 AM
$ABCL For the love of the longs… can we see $8 by April?
0 · Reply
raccoonblackbear
raccoonblackbear Feb. 18 at 2:32 PM
$ABCL Nvidia just sold everything they had of RXRX. Huge hit to the flagship AI biotech company. Think this will send money into companies like ABCL now or will ABCL get dragged down in the process?
1 · Reply
VoidGorilla
VoidGorilla Feb. 17 at 3:23 PM
•• $ABCL $FBIO $SNDX $TGTX ••
0 · Reply
tradersunion353
tradersunion353 Feb. 17 at 3:18 PM
$ABCL Overhyped under performed stock From investors stand point buying and holding is okay but for not for several years with no real gains
1 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 17 at 2:27 PM
$ABCL Short to float ratio now at 21.29% — that’s 48.9 Million shares that must be bought back eventually as margin costs erode potential profits.
0 · Reply
Aye_Rooster
Aye_Rooster Feb. 17 at 1:06 PM
$ABCL Robinhood showing some action in Premarket - up 7.42%
1 · Reply
DragonAlgo
DragonAlgo Feb. 17 at 2:25 AM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2027-01-15 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $1.02 Stop: $0.74 TP1: $1.33 TP2: $1.74 TP3: $2.46 System-defined risk profile. 🔗 https://dragonalgo.com
0 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 16 at 2:07 PM
$ABCL Background for the next ER: The incredibly complex world of developing Monoclonal Antibodies. https://www.tandfonline.com/doi/full/10.1080/19420862.2024.2394229#d1e451 There is a list of abbreviations at the end. This article proves why $ABCL wants to build the best lab in the world and attract the best talent available to defeat the worst diseases on the planet. They did it with Covid. One reason among many that I am a heavy investor in Abcellera Biologics.
2 · Reply
DragonAlgo
DragonAlgo Feb. 16 at 9:31 AM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2027-01-15 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $1.02 Stop: $0.74 TP1: $1.33 TP2: $1.74 TP3: $2.46 System-defined risk profile. 🔗 https://dragonalgo.com
0 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 15 at 12:32 AM
0 · Reply
Rastafari
Rastafari Feb. 14 at 4:43 PM
$ABCL These reflect institutions that have reported new positions or significant increases in ABCL stock in the latest reporting periods (e.g., Q3 2025 – recent 13F filings): • State of Michigan Retirement System – significantly boosted its stake, reporting ~400,000 shares after adding ~350,775 shares (a +712.6% increase).  • Hollencrest Capital Management – acquired a new, albeit small, position in ABCL.  • Caitong International Asset Management Co. Ltd – opened a new position.  • Lantern Wealth Advisors LLC – bought a new stake in the stock.  • Marex Group plc – also reported a new position.  • Goldman Sachs Group Inc. – based on recent filings, appears to have increased its ABCL holdings (very large position noted on MarketBeat data) Goldman position is significant! This bodes well for ABCL.
2 · Reply
BillionerOfKing
BillionerOfKing Feb. 14 at 12:30 AM
$ABCL Current Stock Price: $3.11 Contracts to trade: $3.0 ABCL Feb 20 2026 Call Entry: $0.14 Exit: $0.27 ROI: 97% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DragonAlgo
DragonAlgo Feb. 13 at 11:00 PM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2027-01-15 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $1.02 Stop: $0.74 TP1: $1.33 TP2: $1.74 TP3: $2.46 🔗 https://dragonalgo.com
0 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 13 at 10:45 PM
$ABCL This won’t hurt. https://x.com/PLTRs_Palantir/status/2022280007255482555?s=20
1 · Reply
SultanK
SultanK Feb. 13 at 8:00 PM
$ABCL https://www.nasdaq.com/market-activity/stocks/abcl/institutional-holdings
0 · Reply
Samb2344
Samb2344 Feb. 13 at 4:20 PM
$ABCL patience
2 · Reply
Rastafari
Rastafari Feb. 13 at 4:01 PM
$ABCL State of Michigan baby!
1 · Reply
danchuga
danchuga Feb. 13 at 3:11 PM
0 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 13 at 2:54 PM
0 · Reply
UncleTomFlorida
UncleTomFlorida Feb. 12 at 9:11 PM
$ABCL https://x.com/ScrooogeUncle/status/2021967584195674155?s=20
0 · Reply
Odoji
Odoji Feb. 12 at 7:47 PM
$ABCL leaving this for the fudders, have a nice weekend all try to do something nice w a loved one 💘💉
1 · Reply